Device Craniomaxillofacial

Allograft Bio-Implants

Payments companies reported to CMS as associated with Allograft Bio-Implants. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$17Kassociated payments (2023-2025)
159clinicians with associated payments
1company reporting

By year

2023 $8,585
2024 $5,176
2025 $3,204

Payments reported as associated with Allograft Bio-Implants, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Blood Banking & Transfusion Medicine $3,500
Foot & Ankle Surgery $2,810
Podiatrist $2,428
Orthopaedic Surgery $2,041
Orthodontics and Dentofacial Orthopedics $1,939
Physician Assistant $341

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Allograft Bio-Implants

These are the largest totals companies reported as associated with Allograft Bio-Implants. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Bauer Castle Rock, CO Blood Banking & Transfusion Medicine $3,500.00
John Conner New Albany, IN Orthopaedic Surgery $565.06
Michael Perrone Los Angeles, CA Orthopaedic Surgery $331.72
Maria Yazji Miami, FL Orthodontics and Dentofacial Orthopedics $325.75
Rossana Hoyos Hialeah, FL Orthodontics and Dentofacial Orthopedics $325.75
Samantha Winerman Evanston, IL Foot & Ankle Surgery $184.30
Natalie Domek Chicago, IL Foot & Ankle Surgery $184.30
Jeanette Novara Aventura, FL Dentist $165.45
Neel Patel Miami, FL Oral & Maxillofacial Surgery $165.45
Jose Montero Miami, FL Oral and Maxillofacial Surgery $165.45

Prescribed Allograft Bio-Implants?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.